OTCMKTS:OSIR - Osiris Therapeutics Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $8.66 +0.10 (+1.17 %) (As of 08/21/2018 05:51 AM ET)Previous Close$8.56Today's Range$8.30 - $8.7652-Week Range$4.20 - $13.70Volume20,700 shsAverage Volume31,895 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABeta0.46 Company ProfileChartDividend HistoryEarnings HistoryFinancialsInsider TradesHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Osiris Therapeutics, Inc. researches, develops, manufactures, markets, and distributes regenerative medicine products in the United States. Its products include Grafix and Stravix for treating chronic wounds of diabetic foot ulcers, venous leg ulcers, pressure ulcers, arterial ulcers, and severe burns, as well as surgical and trauma wounds; BIO4 for bone repair and regeneration in spine, trauma, extremity, cranial, and foot and ankle surgeries; and Cartiform for treating articular cartilage lesions in the knee and other joints. The company also develops and markets Menvivo for the repair of meniscus; and TruSkin for treating chronic wounds. It markets and distributes its products directly to physicians, hospitals, and other healthcare providers, as well as through agents and distributors. Osiris Therapeutics, Inc. was founded in 1992 and is headquartered in Columbia, Maryland. Receive OSIR News and Ratings via Email Sign-up to receive the latest news and ratings for OSIR and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Biological products, except diagnostic Sub-IndustryBiotechnology SectorMedical SymbolOTCMKTS:OSIR CUSIP68827R10 Webwww.osiristx.com Phone443-545-1800 Debt Debt-to-Equity RatioN/A Current Ratio1.97 Quick Ratio1.68 Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$118.51 million Price / Sales2.52 Cash FlowN/A Price / CashN/A Book Value$1.20 per share Price / Book7.22 Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/A Miscellaneous Employees350 Outstanding Shares34,530,000Market Cap$0.00 Osiris Therapeutics (OTCMKTS:OSIR) Frequently Asked Questions What is Osiris Therapeutics' stock symbol? Osiris Therapeutics trades on the OTCMKTS under the ticker symbol "OSIR." Who are some of Osiris Therapeutics' key competitors? Some companies that are related to Osiris Therapeutics include Amgen (AMGN), Gilead Sciences (GILD), Biogen (BIIB), NOVOZYMES A/S/S (NVZMY), Seattle Genetics (SGEN), Neurocrine Biosciences (NBIX), Qiagen (QGEN), bluebird bio (BLUE), AveXis (AVXS), BIO-TECHNE (TECH), Ablynx (ABLYF), China Biologic Products (CBPO), Aerie Pharmaceuticals (AERI), argenx (ARGX) and Halozyme Therapeutics (HALO). Who are Osiris Therapeutics' key executives? Osiris Therapeutics' management team includes the folowing people: Mr. Jason Keefer, Interim Pres & CEO (Age 46)Dr. Alla N. Danilkovitch, Chief Scientific Officer (Age 54)Mr. Joel David Rogers, Interim Chief Financial Officer (Age 56)Mr. Edward Yip, Chief Legal Officer & Corp. Sec.Mr. Laine Dyess, VP of Sales Has Osiris Therapeutics been receiving favorable news coverage? Media coverage about OSIR stock has trended somewhat positive recently, Accern reports. Accern identifies positive and negative media coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Osiris Therapeutics earned a news and rumor sentiment score of 0.16 on Accern's scale. They also assigned media coverage about the biotechnology company an impact score of 47.89 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the near term. View Recent Headlines for Osiris Therapeutics. How do I buy shares of Osiris Therapeutics? Shares of OSIR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Osiris Therapeutics' stock price today? One share of OSIR stock can currently be purchased for approximately $8.66. How can I contact Osiris Therapeutics? Osiris Therapeutics' mailing address is 7015 ALBERT EINSTEIN DRIVE, COLUMBIA MD, 21046. The biotechnology company can be reached via phone at 443-545-1800 or via email at [email protected] MarketBeat Community Rating for Osiris Therapeutics (OTCMKTS OSIR)Community Ranking: 2.0 out of 5 ( )Outperform Votes: 97 (Vote Outperform)Underperform Votes: 150 (Vote Underperform)Total Votes: 247MarketBeat's community ratings are surveys of what our community members think about Osiris Therapeutics and other stocks. Vote "Outperform" if you believe OSIR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OSIR will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 8/21/2018 by MarketBeat.com StaffFeatured Article: What does RSI mean?